Dendritic cell subsets in the peritoneal fluid and peripheral blood of women suffering from ovarian cancer

Cytometry Part B - Clinical Cytometry

Volumn 74, Issue 4, 2008, Pages 251-258

  Wertel, I ^a   Polak, G ^a   Bednarek, W ^a   Barczynski B ^a   Rolinski J ^a   Kotarski, J ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Cystadenocarcinoma; Lymphoid DCs; Myeloid DCs; Peritoneal fluid

Indexed keywords

BDCA 1 ANTIGEN; BDCA 2 ANTIGEN; CD123 ANTIGEN; CD19 ANTIGEN; CELL ANTIGEN; MONOCLONAL ANTIBODY;

ADULT; AGED; ARTICLE; BONE MARROW CELL; CANCER PATIENT; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTADENOMA; DENDRITIC CELL; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LYMPHOID CELL; MALIGNANT NEOPLASTIC DISEASE; OVARY CANCER; OVARY CARCINOMA; PERIPHERAL BLOOD MONONUCLEAR CELL; PERITONEAL FLUID; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ASCITIC FLUID; CYSTADENOMA, SEROUS; DENDRITIC CELLS; DISEASE PROGRESSION; FEMALE; FLOW CYTOMETRY; HUMANS; LEUKOCYTES, MONONUCLEAR; MIDDLE AGED; NEOPLASM METASTASIS; OVARIAN NEOPLASMS;

EID: 47549100409     PISSN: 15524949     EISSN: 15524957     Source Type: Journal    
DOI: 10.1002/cyto.b.20410     Document Type: Article

References (31)

1. Guppy AE, Nathan PD, Rustin GJ. Epithelial ovarian cancer: A review of current management. Clin Oncol (R Coll Radiol) 2005;17:399-411.
2. Yancik R. Ovarian cancer. Age contrasts in incidence, histology, disease stage at diagnosis, and mortality. Cancer 1993;71:517-523.
3. Chen L, Ashe S, Brady WA, Hellstrom I, Hellstrom KE, Ledbetter JA, McGowan P, Linsley PS. Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4. Cell 1992;71:1093-1102.
4. Zheng P, Sarma S, Guo Y, Liu Y. Two mechanisms for tumor evasion of preexisting cytotoxic T-cell responses: Lessons from recurrent tumors. Cancer Res 1999;59:3461-3467.
5. Avigan D. Dendritic cells: Development, function and potential use for cancer immunotherapy. Blood Rev 1999;13:51-64.
6. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, Pulendran B, Palucka K. Immunobiology of dendritic cells. Annu Rev Immunol 2000;18:767-811.
7. Di Nicola M, Lemoli RM. Dendritic cells: Specialized antigen presenting cells. Haematologica 2000;85:202-207.
8. Hart DNJ. Dendritic cells: Unique leukocyte populations which control the primary immune response. Blood 1997;90:3245-3287.
9. Olweus J, BitMansour A, Warnke R, Thompson PA, Carballido J, Picker LJ, Lund-Johansen F. Dendritic cell ontogeny: A human dendritic cell lineage of myeloid origin. Proc Natl Acad Sci USA 1997;94:12551-12556.
10. Robinson SP, Patterson S, English N, Davies D, Knight SC, Reid CDL. Human peripheral blood contains two distinct lineages of dendritic cells. Eur J Immunol 1999;29:2769-2778.
11. Dzionek A, Fuchs A, Schmidt P, Cremer S, Zysk M, Miltenyi S, Buck DW, Schmitz J. BDCA-2, BDCA-3, and BDCA-4: Three markers for distinct subsets of dendritic cells in human peripheral blood. J Immunol 2000;165:6037-6046.
12. O'Doherty U, Peng M, Gezelter S, Swiggard WJ, Betjes M, Bhardwaj N, Steinman RM. Human blood contains two subsets of dendritic cells, one immunologically mature and the other immature. Immunology 1994;82:487-493.
13. Grouard G, Rissoan MC, Filgueira L, Durand I, Banchereau J, Liu YJ. The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (TL)-3 and CD40-ligand. J Exp Med 1997;17:1101-1111.
14. Wertel I, Kotarski J, Rolinski J, Bojarska-Junak A, Gogacz M. Evaluation of myeloid and lymphoid dendritic cells in peritoneal fluid in women with non-malignant ovarian tumors. Am J Reprod Immunol 2003;50:238-242.
15. Curiel TJ, Cheng P. Mottram P, Alvarez X, Moons L, Evdemon-Hogan M, Wei S, Zou L, Kryczek I, Hoyle G, Lackner A, Carmeliet P, Zou W. Dendritic cells subsets differentially regulate angiogenesis in human ovarian cancer. Cancer Res 2004;64:5535-5538.
16. Almand B, Resser JR, Lindman B, Nadaf S, Clark JI, Kwon ED, Carbone DP, Gabrilovich DI. Clinical significance of defective dendritic cell differentiation in cancer. Clin Cancer Res 2000;6:1755-1766.
17. Yanagimoto H, Takai S, Satoi S, Toyokawa H, Takahashi K, Terakawa N, Kwon AH, Kamiyama Y. Impaired function of circulating dendritic cells in patients with pancreatic cancer. Clin Immunol 2005;114:52-60.
18. Wischatta M, Sprinzl GM, Gunkel AR, Hussl B, Romani N, Schrott-Fischer A. Dendritic cells in selected head and neck tumors. Ann Otol Rhinol Laryngol 2000;109:56-62.
19. Zehntner S, Townsend W, Parkes J, Schmidt C, Down M, Bell J, Mulligan R, O'Rourke M, Ellem K, Thomas R. Tumor metastasis biopsy as a surrogate marker of response to melanoma immunotherapy. Pathology 1999;31:116-122.
20. Bethwaite PB, Holloway LJ, Thornton A, Delahunt B. Infiltration by immunocompetent cells in early stage invasive carcinoma of the uterine cervix: A prognostic study. Pathology 1996;28:321-327.
21. Eisenthal A, Polyvkin N, Bramante-Schreiber L, Misonznik F, Hassner A, Lifschitz-Mercer B. Expression of dendritic cells in ovarian tumors correlates with clinical outcome in patients with ovarian cancer. Hum Pathol 2001;32:803-807.
22. Nestle FO, Burg G, Fah J, Wrone-Smith T, Nickoloff BJ. Humansun-light-induced basal-cell-carcinoma-associated dendritic cells are deficient in T cell co-stimulatory molecules and are impaired as antigen-presenting cells. Am J Pathol 1997;150:641-651.
23. Staveley-O'Carroll K, Sotomayor E, Montgomery J, Borrello I, Hwang L, Fein S, Pardoll D, Levitsky H. Induction of antigen-specific T cell anergy: An early event in the course of tumor progression. Proc Natl Acad Sci USA 1998;95:1178-1183.
24. Gabrilovich DI, Corak J, Ciernik IF, Kavanaugh D, Carbone DP. Decreased antigen presentation by dendritic cells in patients with breast cancer. Clin Cancer Res 1997;3:483-490.
25. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002;420:860-867.
26. Vicari AP, Caux C. Chemokines in cancer. Cytokine Growth Factor Rev 2002;13:143-154.
27. De la Rosa G, Longo N, Rodriguez-Fernandez JL, Puig-Kroger A, Pineda A, Corbi AL, Sanchez-Mateos P. Migration of human blood dendritic cells across endothelial cell monolayers: Adhesion molecules and chemokines involved in subset-specific transmigration. J Leukoc Biol 2003;73:639-649.
28. Zou W, Machelon V, Coulomb-L'Hermin A, Borvak J, Nome F, Isaeva T, Wei S, Krzysiek R, Durand-Gasselin I, Gordon A, Pustilnik T, Curiel DT, Galanaud P, Capron F, Emilie D, Curiel TJ. Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells. Nat Med 2001;7:1339-1346.
29. Dhodapkar MV, Steinman RM, Krasovsky J, Munz C, Bhardwaj N. Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J Exp Med 2001;193:233-238.
30. Kuwana M. Induction of anergic and regulatory T cells by plasmacytoid dendritic cells and other dendritic cell subsets. Hum Immunol 2002;63:1156-1163.
31. Santin AD, Bellone S, Palmieri M, Bossini B, Cane S, Bignotti E, Roman JJ, Cannon MJ, Pecorelli S. Restoration of tumor specific human leukocyte antigens class I-restricted cytotoxicity by dendritic cell stimulation of tumor infiltrating lymphocytes in patients with advanced ovarian cancer. Int J Gynecol Cancer 2004;14:64-76.